Optibiotix Health (OPTI)

 

OPTI Share PerformanceMore

52 week high101.50 12/11/15
52 week low38.00 29/09/15
52 week change 26.75 (61.85%)
4 week volume5,386,508 01/09/16

Media for (OPTI)

Latest NewsMore

Change of Adviser

RNS Number: 9998K OptiBiotix Health PLC 28 September 2016 OptiBiotix Health plc ("OptiBiotix" or the "Company") Appointment of Broker OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces that it has appointed finnCap as its sole broker with immediate effect. This announc...

Best AIM companies of 2016 named

With the annual AIM Awards just weeks away, former AIM writer of the year Andrew Hore names the impressive small...

OptiBiotix notes issue of equity

OptiBiotix Health has received notification from warrant holders to exercise warrants over 34,050 ordinary shares of 2p ea...

Exercise of Warrants and Issue of Equity

RNS Number: 6613K OptiBiotix Health PLC 23 September 2016 OptiBiotix Health plc ("OptiBiotix" or the "Company") Exercise of Warrants and Issue of Equity OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces that the Company has received notification from warrant holders ...

Holding(s) in Company

RNS Number: 8694J OptiBiotix Health PLC 14 September 2016 OptiBiotix Health plc ("OptiBiotix" or the "Company") Holding in Company The Company was informed on 13 September 2016 that Seneca Partners Limited no longer has a disclosable interest in the Company. This announcement contains inside information for the purposes of Article 7 of EU Regulation...

Consumer survey results of GoFigure products

RNS Number: 0029J OptiBiotix Health PLC 06 September 2016 OptiBiotix Health plc ("OptiBiotix" or the "Company") Consumer Survey of GoFigure products OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, announces the results of an independ...

3 small-caps to buy after today’s results?

Henry Boot (LSE:BHY) reported a strong performance in its half-year results this morning. The group, whose operations ex...

OptiBiotix widens H1 loss, makes progress

OptiBiotix has widened its H1 pretax loss to 0.7m, from a loss of 0.5m. Revenue was just 88,252, from nil. Administrative exp...

Fundamental DataMore

EPS-1.75
Dividend yield0 %

Equity Research (OPTI)

OptiBiotix Health plc
30/08/2016
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has reported another half (to May 2016) of strong scientific and commercial progress. Operational...
OptiBiotix Health plc
28/07/2016
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has announced the successful completion of a trial launch for its Slimbiome® ingredients in a range of...
OptiBiotix Health plc
19/07/2016
New patent filing suggests multiple routes to market for cholesterol strain The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has announced the filing...

Latest discussion posts More

  • S O'Hara 210916

    interview http://www.youtube.com/watch?v=KHGom08tnsI mol
    21-Sep-2016
    mol42
  • Re: Seneca now out of OPTI...

    Looks like you're already in profit and I think Senecs were selling at 70p so 69p is a great price. GD
    15-Sep-2016
    Go Dink
  • Re: Seneca now out of OPTI...

    Couldn't quite get any yesterday at sub 68.5 but mid 69 was good enough.
    15-Sep-2016
    Owen Nobody

Users' HoldingsMore

Users who hold Optibiotix Health also hold..
LLOYDS GRP.16%
NATIONAL GRID9%
BP9%
VODAFONE GRP.8%
CONCEPTA8%

Codes & Symbols

ISINGB00BP0RTP38
SymbolsOPTI, LSE:OPTI, OPTI.L, OPTI:LN, LON:OPTI, XLON:OPTI